GPR183 and cancer: To investigate how the upregulation of GPR183 in cancer cells could impact their recognition and phagocytosis by M1 macrophages, two Raji-GPR183KO single-clones (clone #1 and clone #2) were generated by CRISPR/Cas9 gene editing (Figure 3A) using previously described procedures (14).